SCHEMBL826798

SCHEMBL826798

O=S(=O)(/C=C/c1ccc(F)cc1)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
PKM P14618 1/20 0.50
NFE2L2 Q16236 1/20 0.50
GPR183 P32249 4/20 0.49
MEN1 O00255 2/20 0.44
FAAH O00519 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
ELANE P08246 1/20 0.44
PRTN3 P24158 1/20 0.44
PRSS3 P35030 1/20 0.44
BRAF P15056 1/20 0.44
LMNA P02545 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2B Q13224 1/20 0.43
CYP2D6 P10635 1/20 0.41
HTR2A P28223 1/20 0.41
MAOB P27338 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL826799 1.00 KMT2A (0.50) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL1194732 1.00 KMT2A (0.50) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL5074683 0.93 KMT2A (0.54) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL5074689 0.93 KMT2A (0.54) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL1194433 0.91 KMT2A (0.51) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL1194500 0.91 KMT2A (0.51) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL1194436 0.91 KMT2A (0.51) KMT2APKMNFE2L2GPR183MEN1
SCHEMBL5973925 0.88 PPARG (0.47) KMT2APKMNFE2L2FAAHPRSS1
SCHEMBL513626 0.88 PPARG (0.47) KMT2APKMNFE2L2FAAHPRSS1
SCHEMBL513627 0.88 PPARG (0.47) KMT2APKMNFE2L2FAAHPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896401-B1 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS UNIV TEMPLE (US) 2013-04-10 EP claimed
US-8143453-B2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Temple University—Of the Commonwealth System of Higher Education (US) 2012-03-27 US claimed
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-05-14 US claimed
EP-1896401-B1 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS UNIV TEMPLE (US) 2013-04-10 EP disclosed
US-8143453-B2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Temple University—Of the Commonwealth System of Higher Education (US) 2012-03-27 US disclosed
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis SULT2A1, SULT1A1, ARSA KMT2A 2578/4885PKM 3996/4885NFE2L2 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.